Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy 
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge 
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO 
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow 
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth 
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says 
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal 
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand 
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest 
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia 
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices 
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership 
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside 
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement 
SHANGHAI, China, April 24, 2018 -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced that members of the senior management team will participate at two upcoming investor conferences. Details of the presentations are as follows:
J.P. Morgan’s Global China Summit
Panel: Innovative Healthcare Panel
Date: Tuesday, May 8, 2018
Location: Beijing, China
Panel Time: 4:00pm CST
Bank of America Merrill Lynch Healthcare Conference
Date: Thursday, May 17, 2018
Location: Las Vegas, Nevada
Presentation Time: 8:00am PST
Individuals may access a live webcast of the Bank of America Merrill Lynch Healthcare Conference presentation on the Zai Lab website at www.zailaboratory.com under "Events & Presentations" in the "Investors" section. A replay of the webcast will be available on this site for 90 days following the live event.
About Zai Lab
Zai Lab (NASDAQ:ZLAB) is a Shanghai-based innovative biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. The company’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast growing segments of China’s pharmaceutical market and global unmet medical needs. Zai Lab’s vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partners’ and its own products in order to impact human health worldwide.
Contact:
Zai Lab
Billy Cho
+86 137 6151 2501
[email protected]
Solebury Trout
John Graziano
+1 646 378 2942
[email protected]
